Merck Profit Beats Analyst Estimates on Diabetes Drug Sales - BusinessWeek

Globe and Mail

Merck Profit Beats Analyst Estimates on Diabetes Drug Sales BusinessWeek 2 (Bloomberg) -- Merck & Co., the second-largest US drugmaker, reported fourth-quarter profit that topped analyst estimates on higher sales of the Januvia diabetes drug. The company forecast 2012 earnings that matched estimates. Merck Reports Q4 Results; Higher Diabetes Drug Sales Boosts Profit – NYSE:MRKGalaxy Stocks Merck Reports Mixed Q4, 2012 Outlook Below ForecastsInvestor's Business Daily all 259 news articles »